Showing results (1391-1400 of 2,818) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|September 19, 2026
Association Between Continuous Glucose Monitoring Utilization and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Type 2 Diabetes: A Real-World StudyEugene E Wright, Eileen Huang, Anila BindalDiabetes Technology & Therapeutics|June 28, 2003
Overcoming the barriers for achieving standards of diabetes care: the formation of CADREWilliam T Cefalu, Derek LeRoith, Diabetes Technology & Therapeutics|June 28, 2003
The role of the independent variable to glucose sensor calibrationAntonios E Panteleon, Kerstin Rebrin, Garry M SteilDiabetes Technology & Therapeutics|June 28, 2003
Research use of the AIDA www.2aida.org diabetes software simulation program: a review-part 1. decision support testing and neural network trainingEldon D LehmannDiabetes Technology & Therapeutics|June 28, 2003
Measurement of insulin-like growth factor-I during military operational stress via a filter paper blood spot assayBradley C Nindl, Mark D Kellogg, M Javad Khosravi, et al.Diabetes Technology & Therapeutics|July 23, 2003
Glucose sensing in transdermal body fluid collected under continuous vacuum pressure via micropores in the stratum corneumSuzanne Gebhart, Mark Faupel, Richard Fowler, et al.Diabetes Technology & Therapeutics|July 23, 2003
Pathophysiologic implications of angiotensin I-converting enzyme as a mechanosensor: diabetesD W MoskowitzDiabetes Technology & Therapeutics|February 5, 2011
Lipoprotein-associated phospholipase A₂ activity predicts progression of subclinical coronary atherosclerosisGregory L Kinney, Janet K Snell-Bergeon, David M Maahs, et al.Diabetes Technology & Therapeutics|February 5, 2011
Comparing the efficacy of α-glucosidase inhibitors in suppressing postprandial hyperglycemia using continuous glucose monitoring: a pilot study-the MAJOR studyDaisuke Tsujino, Rimei Nishimura, Kentaro Taki, et al.Diabetes Technology & Therapeutics|December 24, 2010
Hypoglycemia risk and glucose variability indices derived from routine self-monitoring of blood glucose are related to laboratory measures of insulin sensitivity and epinephrine counterregulationAchilleas N Pitsillides, Stacey M Anderson, Boris KovatchevPageof 282